Friday, July 5, 2019

LAWSUIT FILED AGAINST TEXAS BOARD OF PHARMACY CHALLENGES RULE BARRING DOCTORS FROM DISPENSING MEDS Pharmacy protection plan in Texas attacked Published: 19 hours ago

https://www.wnd.com/2019/07/lawsuit-challenges-rule-barring-doctors-from-dispensing-meds/

meningitis-etc: Ronzio Sentencing Canceled

meningitis-etc: Ronzio Sentencing Canceled: By Walter F. Roche Jr. The sentencing of the key government witness in the criminal probe of a deadly fungal meningitis outbreak has been...

meningitis-etc: Prosecutors File Appeal Notice on Acquittals

meningitis-etc: Prosecutors File Appeal Notice on Acquittals: By Walter F. Roche Jr. Federal prosecutors have filed a notice of appeal of the ruling by a federal judge reversing the unanimous guilty ...
3 days ago - Counterfeit drugs can impact the pharmaceutical industry and patients. ... The draft includes a “full traceability” mechanism and drug recall system. ... produced a handheld device which can assess the compound of a drug in real time.15 This is

FDA warning: Do not use repackaged bevacizumab from AmEx ...

4 days ago - Although the FDA recommended that AmEx Pharmacy voluntarily recall all unexpired drugsintended to be sterile and cease sterile operations on June 25, 2019 ...
Missing: compound ‎| Must include: compound
6 days ago - §291.7 Prescription Drug Recalls by the Manufacturer . .... §291.36 Pharmacies Compounding Sterile Preparations (Class A-S) .
3 days ago - Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the prescription drug products and lots, within expiry, distributed during the time ...

Seven jailed after PANT investigations; Fentanyl laced drugs seized

https://www.verdenews.com/news/2019/jul/05/seven-jailed-after-pant-investigations-fentanyl-la/

FCA Decision Tracker: More Interpretations Of Escobar

https://www.law360.com/articles/1173584/fca-decision-tracker-more-interpretations-of-escobar

United States: Podcast: Non-Binding Guidance: Examining FDA's Enforcement Authority Over Stem Cell Clinics And Compounders Last Updated: July 4 2019 Article by Gregory H. Levine and Beth P. Weinman Ropes & Gray LLP

http://www.mondaq.com/unitedstates/x/821872/Life+Sciences+Biotechnology/Podcast+NonBinding+Guidance+Examining+FDAs+Enforcement+Authority+Over+Stem+Cell+Clinics+And+Compounders